Horizon Discovery Edit-R crRNA libraries adopted by AstraZeneca as part of its functional genomics discovery platform

Location: Cambridge, UK 14/09/2018 AstraZeneca joins Horizon’s Genomics Discovery Initiative CRISPR knockout and activation libraries are a key toolset in early research crRNA libraries are an efficient and convenient platform for gain- and loss-of-function studies Cambridge, UK, 14 September 2018: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene... Read more

Large-Scale Global Genome Projects Choose PacBio Sequencing to Help Decode Life

MENLO PARK, Calif., Sept. 13, 2018 (GLOBE NEWSWIRE) — When creating a genomic ark of creatures great and small, scientists across the globe are turning to the comprehensive coverage and quality of long-read sequencing technology from Pacific Biosciences (Nasdaq:PACB), the leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes.Today, the Vertebrate Genomes Project (VGP),... Read more

Large-Scale Global Genome Projects Choose PacBio Sequencing to Help Decode Life

MENLO PARK, Calif., Sept. 13, 2018 (GLOBE NEWSWIRE) — When creating a genomic ark of creatures great and small, scientists across the globe are turning to the comprehensive coverage and quality of long-read sequencing technology from Pacific Biosciences (Nasdaq:PACB), the leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes.Today, the Vertebrate Genomes Project (VGP),... Read more

Seven Bridges & e-NIOS Partnership to Break the Biomarker Bottleneck

September 11, 2018 Cambridge, Mass. and Athens, Greece., Sept 11, 2018. Seven Bridges, the leading biomedical data platform and analytics company, and e-NIOS, a biological knowledge discovery start-up, announced a strategic partnership towards data-driven discovery of biomarker signatures. Derivation of robust biomarkers from next generation sequencing and multi-omic data is currently a major bottleneck in precision medicine... Read more

Seven Bridges announces the launch of largest pediatric data resource as a member of the Gabriella Miller Kids First Data Resource Center

September 10, 2018 Cambridge, Mass. Sept 10, 2018. Seven Bridges, the leading biomedical data platform and analytics company, today announced the launch of the new Kids First Data Resource Portal with the Gabriella Miller Kids First Data Resource Center (DRC) at the Center for Data Driven Discovery in Biomedicine (D3b) at Children’s Hospital of Philadelphia. The Gabriella Miller Kids First Data Resource... Read more

Neogen acquires Livestock Genetic Services

CONTACT: Steve Quinlan, Vice President & CFO, 517/372-9200 LANSING, Mich., Sept. 4, 2018 — Neogen Corporation (NASDAQ: NEOG) announced today that it has acquired the assets of Livestock Genetic Services, LLC, a Virginia-based company that specializes in genetic evaluations and data management for cattle breeding organizations. The acquisition of Livestock Genetic Services (LGS) enhances Neogen’s... Read more

Thermo Fisher global visited Genetron Health to jointly develop gene sequencing platform applications

BEIJING, Sept. 3, 2018 /PRNewswire/ — On August 29, 2018, Mr. Joydeep Goswami, the President of Clinical NGS and Oncology Thermo Fisher Scientific (hereinafter referred to as Thermo Fisher), and Mr. Peter Vuong, the Director of Global Product Management, Clinical NGS division Thermo Fisher visited the Beijing headquarters of Genetron Health, conducted in-depth discussions on strategic... Read more

Swift Biosciences Launches Swift Amplicon HS Panels, Enabling Confident Targeted Detection of Low Frequency Variants from Liquid Biopsy Sequencing

(ANN ARBOR, Mich. – Aug. 28, 2018 ) Swift Biosciences today announced early access availability of its Swift Amplicon HS Panels, a new, high-sensitivity targeted amplicon library preparation kit for next-generation sequencing (NGS) of liquid biopsy samples, including cell-free DNA (cfDNA). This addition to Swift’s targeted NGS portfolio facilitates the detection and validation of mutations occurring at... Read more